BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38448348)

  • 1. Association of autoimmune pancreatitis and intraductal papillary mucinous neoplasm. A retrospective analysis from a tertiary care referral center.
    Lanzillotta M; Belli LI; Belfiori G; Palumbo D; Schiavo-Lena M; Capurso G; Arcidiacono PG; Dagna L; Falconi M; Crippa S; Della-Torre E
    Pancreatology; 2024 May; 24(3):456-462. PubMed ID: 38448348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of IgG4 response and autoimmune pancreatitis with intraductal papillary-mucinous neoplasms.
    Hedayat AA; Lisovsky M; Suriawinata AA; Longnecker DS
    Pancreatology; 2017; 17(2):263-266. PubMed ID: 28215485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraduct papillary mucinous neoplasm of the pancreas: a tumour linked with IgG4-related disease?
    Bateman AC; Culver EL; Sommerlad M; Chetty R
    J Clin Pathol; 2013 Aug; 66(8):671-5. PubMed ID: 23596150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraductal papillary mucinous neoplasm of the pancreas and IgG4-related disease: a coincidental association.
    Tabata T; Kamisawa T; Hara S; Kuruma S; Chiba K; Kuwata G; Fujiwara T; Egashira H; Koizumi S; Endo Y; Koizumi K; Fujiwara J; Arakawa T; Momma K; Horiguchi S; Hishima T; Kurata M; Honda G; Kloppel G
    Pancreatology; 2013; 13(4):379-83. PubMed ID: 23890136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare coincidence of intraductal papillary mucinous neoplasm and type 1 autoimmune pancreatitis.
    Suzuki R; Okada R; Muto M; Takagi T; Sugimoto M; Irie H; Nakamura J; Takasumi M; Kato T; Hashimoto M; Notohara K; Suzuki O; Hashimoto Y; Hikichi T; Marubashi S; Ohira H
    Clin J Gastroenterol; 2020 Dec; 13(6):1315-1321. PubMed ID: 32594422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexisting Type 1 Autoimmune Pancreatitis and Mixed-type Intraductal Papillary Mucinous Neoplasm.
    Hirano K; Itoi T; Sasahira N; Koyama H; Ihara F
    Intern Med; 2021 Sep; 60(17):2793-2797. PubMed ID: 33746160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of efficacy of pancreatic juice cytology for risk classification according to international consensus guidelines in patients with intraductal papillary mucinous neoplasm; a retrospective study.
    Yamakawa K; Masuda A; Nakagawa T; Shiomi H; Toyama H; Takenaka M; Sakai A; Kobayashi T; Tsujimae M; Ashina S; Yamada Y; Tanaka T; Tanaka S; Nakano R; Sato Y; Ikegawa T; Kurosawa M; Fujigaki S; Kutsumi H; Itoh T; Fukumoto T; Kodama Y
    Pancreatology; 2019 Apr; 19(3):424-428. PubMed ID: 30857854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute pancreatitis in intraductal papillary mucinous neoplasm: a single-center retrospective cohort study with systematic review and meta-analysis.
    Xu JH; Ni CY; Zhuang YY; Li L; Lin Y; Xia ZS; Wu WR; Chen QK; Zhong W
    BMC Gastroenterol; 2023 Dec; 23(1):424. PubMed ID: 38041073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraductal papillary mucinous neoplasm of pancreas: Clinicopathological features and long-term survival after surgical resection.
    Revoredo Rego F; Reaño Paredes G; de Vinatea de Cárdenas J; Herrera Chávez G; Kometter Barrios F; Arenas Gamio J
    Cir Esp (Engl Ed); 2023 Nov; 101(11):736-745. PubMed ID: 36716959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic inflammatory changes and oxidative stress in the background of "pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm".
    Matsuda R; Miyasaka Y; Yamada Y; Kawata J; Sakihama K; Yamamoto T; Saeki K; Yamamoto H; Ohishi Y; Koga Y; Nakamura M; Oda Y
    Virchows Arch; 2020 Dec; 477(6):799-806. PubMed ID: 32468246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms.
    Oyama H; Tada M; Takagi K; Tateishi K; Hamada T; Nakai Y; Hakuta R; Ijichi H; Ishigaki K; Kanai S; Kogure H; Mizuno S; Saito K; Saito T; Sato T; Suzuki T; Takahara N; Morishita Y; Arita J; Hasegawa K; Tanaka M; Fukayama M; Koike K
    Gastroenterology; 2020 Jan; 158(1):226-237.e5. PubMed ID: 31473224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anatomical pancreatic variants in intraductal papillary mucinous neoplasm patients: a cross-sectional study.
    Johansson K; Mustonen H; Seppänen H; Lehtimäki TE
    BMC Gastroenterol; 2022 Aug; 22(1):394. PubMed ID: 35989322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of intraductal papillary mucinous neoplasm manifesting as acute pancreatitis or acute recurrent pancreatitis.
    Jang JW; Kim MH; Jeong SU; Kim J; Park DH; Lee SS; Seo DW; Lee SK; Kim JH
    J Gastroenterol Hepatol; 2013 Apr; 28(4):731-8. PubMed ID: 23301513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trajectory of intraductal papillary mucinous neoplasms progressing to pancreatic carcinomas during long-term surveillance: a prospective series of 100 carcinoma cases.
    Oyama H; Hamada T; Nakai Y; Tanaka M; Endo G; Hakuta R; Ishida K; Ishigaki K; Kanai S; Kurihara K; Saito T; Sato T; Suzuki T; Suzuki Y; Takaoka S; Tange S; Tokito Y; Takahara N; Ushiku T; Fujishiro M
    J Gastroenterol; 2023 Oct; 58(10):1068-1080. PubMed ID: 37507590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus in intraductal papillary mucinous neoplasm of the pancreas is associated with high-grade dysplasia and invasive carcinoma.
    Morales-Oyarvide V; Mino-Kenudson M; Ferrone CR; Sahani DV; Pergolini I; Negreros-Osuna AA; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
    Pancreatology; 2017; 17(6):920-926. PubMed ID: 28890154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic Resection for Side-Branch Intraductal Papillary Mucinous Neoplasm (SB-IPMN): a Contemporary Single-Institution Experience.
    Dortch JD; Stauffer JA; Asbun HJ
    J Gastrointest Surg; 2015 Sep; 19(9):1603-9. PubMed ID: 26055134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of 3-T MR imaging in intraductal papillary mucinous neoplasm with a concomitant invasive carcinoma.
    Sotozono H; Kanki A; Yasokawa K; Yamamoto A; Sanai H; Moriya K; Tamada T
    Eur Radiol; 2022 Dec; 32(12):8276-8284. PubMed ID: 35665843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraductal papillary mucinous neoplasm of the accessory pancreatic duct in the pancreas uncinate process: A case report.
    Guo T; Liu Y; Yang Z; Li J; You K; Zhao D; Chen S; Li C; Yang P; Hu H; Zhang H
    Medicine (Baltimore); 2023 May; 102(21):e33840. PubMed ID: 37233442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Pancreatitis Finding by Endoscopic Ultrasonography in the Pancreatic Parenchyma of Intraductal Papillary Mucinous Neoplasms Is Associated with Invasive Intraductal Papillary Mucinous Carcinoma.
    Takenaka M; Masuda A; Shiomi H; Yagi Y; Zen Y; Sakai A; Kobayashi T; Arisaka Y; Okabe Y; Kutsumi H; Toyama H; Fukumoto T; Ku Y; Kudo M; Azuma T
    Oncology; 2017; 93 Suppl 1():61-68. PubMed ID: 29258092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome after surgery for invasive intraductal papillary mucinous neoplasia compared to conventional pancreatic ductal adenocarcinoma - A Swedish nationwide register-based study.
    Holmberg M; Radkiewicz C; Strömberg C; Öman M; Ghorbani P; Löhr JM; Sparrelid E
    Pancreatology; 2023 Jan; 23(1):90-97. PubMed ID: 36522260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.